Vitamin Deficiency Treatment Market (Product Type: Vitamin B Complex Supplements, Vitamin C, Vitamin A , Vitamin D, Vitamin E, and Vitamin K; Route of Administration: Oral and Parenteral; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 - 2028

Description

Growing Prevalence of Vitamin Deficiency Cases Worldwide to Propel Market Growth

The healthcare sector is continually finding new ways to address the burdening problems associated with vitamin deficiencies. As the number of individuals suffering from vitamin deficiencies continues to grow at an exponential rate worldwide, vitamin deficiency treatments have gained a great amount of attention over the past couple of decades. Some of the major factors that are expected to influence the expansion of the vitamin deficiency treatment market during the forecast period include rising prevalence of acute and chronic disorders, surge in the number of research & development activities, and growing demand for vitamin D and vitamin B complex, owing to the health benefits.

At present, a great number of research activities are focusing on addressing health issues and risks involved with nutritional deficiencies. Vitamin D testing and treatment has witnessed considerable growth in the past few years. Guidelines pertaining to the treatment of various vitamin deficiencies continue to evolve due to research. As vitamin D deficiency continues to emerge as a global burden, apart from vitamin deficiency treatment, tackling vitamin D deficiency would require robust public health actions, including vitamin D food fortification. At the back of these factors, the global vitamin deficiency treatment market is expected to reach a value of ~US$ 9.5 Bn by the end of 2027.

Notable Progress to Address Vitamin B12 and Vitamin D Deficiencies

Vitamin deficiencies continue to pose a major threat to the overall wellbeing of the society worldwide. Vitamin deficiencies can lead to irritability, nausea, constipation, depression, mental confusion, and muscle weakness, among others. Vitamin B12 deficiencies have increasingly been detected among athletes, individuals with high alcohol consumption, and women who consistently use birth control pills. In the current scenario, the demand for vitamin deficiency treatment is on the rise to address and predominantly incorporate a blend of vitamin B6 with synergistic B vitamins. For several decades, within clinical practices worldwide, vitamin B12 deficiencies often received a blind eye or were misdiagnosed. However, at present, trends suggest that detection, diagnosis, and vitamin deficiency treatment continue to progress at an impressive pace. Diagnosis based on low serum B12 levels and elevated biomarkers including methylmalonic acid and homocysteine continue to make headlines within the vitamin deficiency treatment market. In the current scenario, researchers are also investigating the potential benefits of deploying oral supplementation to combat the symptoms of vitamin B12 deficiency as an alternative to parental treatment.

Get a glimpse of the in-depth analysis through our Report Brochure

Over the past decade and during the forecast period, researchers are increasingly exploring the potential solutions to address muscle weakness among the elderly population caused by vitamin D deficiency. The prevalence of vitamin D deficiency has witnessed unprecedented growth over the past few years, due to which the demand for supplementation of 800 IU of vitamin D is required. In most cases, vitamin D is predominantly administered in the form of cholecalciferol. The demand for cholecalciferol is expected to grow in the coming years, as it is considered to be safe for elderly people. The demand for vitamin B complex supplements is projected to remain the highest among all other types of products followed by vitamin C and vitamin D supplements.

Companies Likely to Focus on Research & Development Activities to Gain Advantage

Participants operating in the current vitamin deficiency treatment market are expected to focus on research and development activities to discover new and improved vitamin deficiency treatments. Several companies are also anticipated to eye opportunities in foreign markets, while simultaneously improving their market share in the domestic market. Product launches and expanding the product portfolio are also projected to remain some of the key strategies deployed by market players. For instance, in 2016, Abbott Laboratories expanded its product portfolio by launching two infant nutrition products, including Similac Pro-Advance and Pro-Sensitive. Several companies are also leaning toward inorganic growth strategies such as mergers & acquisitions to improve their market share and brand presence. For instance, Pfizer, Inc. acquired Emergen C in 2012, at the back of which, the sales of Pfizer saw remarkable growth.

Analysts’ Viewpoint

The global vitamin deficiency treatment market is expected to grow at a CAGR of 6.5% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising prevalence of vitamin D deficiencies among the elderly population, significant development on the research front, growing emphasis on drug development, and rising awareness pertaining to vitamin deficiencies. Companies operating in the vitamin deficiency treatment market landscape should focus on mergers & acquisitions to improve their market share and overall position. Product launches, research, and expansion of the existing product portfolio are some of the other strategies that should be considered to gain ground in the current vitamin deficiency treatment market during the assessment period. 

Vitamin Deficiency Treatment Market: Overview

The global vitamin deficiency treatment market for the historical period 2018–2019 and forecast period 2020–2028, rise in global geriatric population and high demand for Vitamin D and Vitamin B complex due to numerous health benefits are projected to drive the global vitamin deficiency treatment market

According to the report, the global vitamin deficiency treatment market was valued at US$ 5.46 Bn in 2019 and is anticipated to expand at a CAGR of 6.5% from 2020 to 2028

High Demand for Vitamin D and Vitamin B Complex due to Numerous Health Benefits: Key Drivers

Vitamin D plays a significant role in absorbing calcium into the bones, thereby aiding in building and maintaining strong bones. Vitamin D also helps maintain normal blood levels of calcium and phosphorus. Role of Vitamin D supplements is not just restricted to preventing or treating rickets, but it is also known to help maintain normal function of the immune system, normal inflammatory response, and normal muscle function.

Vitamin D deficiency is quite common, especially in the young working population, as more and more people are leading a sedentary lifestyle and have a desk job. These people do not receive enough sunlight to activate vitamin D formation in the body, which is leading to increase in vitamin D deficiency.

These factors are expected to increase the demand for vitamin D supplements and subsequently, drive the global vitamin deficiency treatment market

Vitamin B12, also known as methylcobalamin, is a water-soluble vitamin that plays significant role in the production of red blood cells and DNA, as well as proper functioning of the nervous system. B12 deficiency can cause numerous issues including pernicious anemia, megaloblastic anemia, and sub-acute combined degeneration of spinal cord. Vitamin B12 is derived from animal products such as meat, poultry fish, dairy, and is frequently found to be deficient in vegetarians and vegans.

Vitamin B complex is a commonly prescribed vitamin supplement due to their high functionality in maintaining normal body metabolism, thus, driving the global vitamin deficiency treatment market

Rise in Global Geriatric Population

Rise in global geriatric population is estimated to fuel the demand for vitamins and other dietary supplements at a steep pace during the forecast period. Rise in geriatric population directly affects the demand for vitamins, primarily due to higher susceptibility to various diseases among this population.

Most developed countries have high geriatric population. According to the WHO, the geriatric population is expected to rise at a rapid pace in developed countries such as the U.S., the U.K., and Japan

Access to various diagnostic and treatment services has improved due to favorable healthcare policies and the advancement in health care facilities in countries such as the U.S., Japan, the U.K., and other countries in Western Europe, which, in turn, has increased life expectancy of the population. Increase in geriatric population is anticipated to propel the vitamin deficiency treatment market during the forecast period.

Lack of Awareness in Developing Countries to Restrain Global Vitamin Deficiency Treatment Market

Vitamin deficiency mostly occurs due to lack of proper dietary nutrition in underdeveloped countries

However, a significant number of cases of vitamin deficiency is expected to remain undetected, especially in developing countries such as India and China, making vitamin deficiency a highly under-diagnosed disorder. Lack of awareness about such disorders in underdeveloped and developing countries is expected to restrain the global vitamin deficiency treatment market during the forecast period.

Vitamin Deficiency Treatment Market: Competition Landscape

This report profiles major players in the global vitamin deficiency treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The vitamin deficiency treatment market is highly fragmented, with the presence of a few large players in international markets and many small players in regional markets

Prominent players operating in the global vitamin deficiency treatment market include 

  • Merck & Co., Inc.
  • Nature’s Bounty
  • Sandoz International (Novartis)
  • DSM
  • Lonza

Key Questions Answered in Global Vitamin Deficiency Treatment Market Report

  • What is the scope of growth of companies in the global vitamin deficiency treatment market?
  • What will be the Y-o-Y growth of the global vitamin deficiency treatment market between 2020 and 2028?
  • What is the influence of changing trends in technologies on the global vitamin deficiency treatment market?
  • Will North America continue to be the most profitable market for vitamin deficiency treatment providers?
  • Which factors will hamper the growth of the global vitamin deficiency treatment market during the forecast period?
  • Which are the leading companies in the global vitamin deficiency treatment market?

Vitamin Deficiency Treatment Market - Segmentation

Product Type

  • Vitamin B Complex Supplements
  • Vitamin C (Ascorbic Acid)
  • Vitamin A (Retinoids)
  • Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)
  • Vitamin E (Tocopherol)
  • Vitamin K

Route of Administration

  • Oral
  • Parenteral

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Vitamin Deficiency Treatment Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Vitamin Deficiency Treatment Market Analysis and Forecast, 2018–2030

5. Key Insights

    5.1. Regulatory Scenario, by Region

    5.2. Value Chain Analysis

6. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Product Type 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Product Type, 2018–2030

        6.3.1. Vitamin B Complex Supplements

        6.3.2. Vitamin C (Ascorbic Acid)

        6.3.3. Vitamin A (Retinoids)

        6.3.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        6.3.5. Vitamin E (Tocopherol)

        6.3.6. Vitamin K

    6.4. Market Attractiveness, by Product Type 

7. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Route of Administration 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Route of Administration, 2018–2030

        7.3.1. Oral

        7.3.2. Parenteral

    7.4. Market Attractiveness, by Route of Administration 

8. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Distribution Channel 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Distribution Channel, 2018–2030

        8.3.1. Hospital Pharmacies

        8.3.2. Retail Pharmacies

        8.3.3. Online Pharmacies

    8.4. Market Attractiveness, by Distribution Channel 

9. Global Vitamin Deficiency Treatment Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Market Attractiveness, by Region

10. North America Vitamin Deficiency Treatment Market Analysis and Forecast

    10.1. Introduction

    10.2. Market Value Forecast, by Product Type, 2018–2030

        10.2.1. Vitamin B Complex Supplements

        10.2.2. Vitamin C (Ascorbic Acid)

        10.2.3. Vitamin A (Retinoids)

        10.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        10.2.5. Vitamin E (Tocopherol)

        10.2.6. Vitamin K

    10.3. Market Value Forecast, by Route of Administration, 2018–2030

        10.3.1. Oral

        10.3.2. Parenteral

    10.4. Market Value Forecast, by Distribution Channel, 2018–2030

        10.4.1. Hospital Pharmacies

        10.4.2. Retail Pharmacies

        10.4.3. Online Pharmacies

    10.5. Market Value Forecast, by Country, 2018–2030

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis 

        10.6.1. By Product Type 

        10.6.2. By Route of Administration 

        10.6.3. By Distribution Channel 

        10.6.4. By Country

11. Europe Vitamin Deficiency Treatment Market Analysis and Forecast

    11.1. Introduction

    11.2. Market Value Forecast, by Product Type, 2018–2030

        11.2.1. Vitamin B Complex Supplements

        11.2.2. Vitamin C (Ascorbic Acid)

        11.2.3. Vitamin A (Retinoids)

        11.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        11.2.5. Vitamin E (Tocopherol)

        11.2.6. Vitamin K

    11.3. Market Value Forecast, by Route of Administration, 2018–2030

        11.3.1. Oral

        11.3.2. Parenteral

    11.4. Market Value Forecast, by Distribution Channel, 2018–2030

        11.4.1. Hospital Pharmacies

        11.4.2. Retail Pharmacies

        11.4.3. Online Pharmacies

    11.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis 

        11.6.1. By Product Type 

        11.6.2. By Route of Administration 

        11.6.3. By Distribution Channel 

        11.6.4. By Country/Sub-region

12. Asia Pacific Vitamin Deficiency Treatment Market Analysis and Forecast

    12.1. Introduction

    12.2. Market Value Forecast, by Product Type, 2018–2030

        12.2.1. Vitamin B Complex Supplements

        12.2.2. Vitamin C (Ascorbic Acid)

        12.2.3. Vitamin A (Retinoids)

        12.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        12.2.5. Vitamin E (Tocopherol)

        12.2.6. Vitamin K

    12.3. Market Value Forecast, by Route of Administration, 2018–2030

        12.3.1. Oral

        12.3.2. Parenteral

    12.4. Market Value Forecast, by Distribution Channel, 2018–2030

        12.4.1. Hospital Pharmacies

        12.4.2. Retail Pharmacies

        12.4.3. Online Pharmacies

    12.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis 

        12.6.1. By Product Type 

        12.6.2. By Route of Administration 

        12.6.3. By Distribution Channel 

        12.6.4. By Country/Sub-region

13. Latin America Vitamin Deficiency Treatment Market Analysis and Forecast

    13.1. Introduction

    13.2. Market Value Forecast, by Product Type, 2018–2030

        13.2.1. Vitamin B Complex Supplements

        13.2.2. Vitamin C (Ascorbic Acid)

        13.2.3. Vitamin A (Retinoids)

        13.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        13.2.5. Vitamin E (Tocopherol)

        13.2.6. Vitamin K

    13.3. Market Value Forecast, by Route of Administration, 2018–2030

        13.3.1. Oral

        13.3.2. Parenteral

    13.4. Market Value Forecast, by Distribution Channel, 2018–2030

        13.4.1. Hospital Pharmacies

        13.4.2. Retail Pharmacies

        13.4.3. Online Pharmacies

    13.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis 

        13.6.1. By Product Type 

        13.6.2. By Route of Administration 

        13.6.3. By Distribution Channel 

        13.6.4. By Country/Sub-region

14. Middle East & Africa Vitamin Deficiency Treatment Market Analysis and Forecast

    14.1. Introduction

    14.2. Market Value Forecast, by Product Type, 2018–2030

        14.2.1. Vitamin B Complex Supplements

        14.2.2. Vitamin C (Ascorbic Acid)

        14.2.3. Vitamin A (Retinoids)

        14.2.4. Vitamin D (Calciferol, 1,25-dihydroxy Vitamin D)

        14.2.5. Vitamin E (Tocopherol)

        14.2.6. Vitamin K

    14.3. Market Value Forecast, by Route of Administration, 2018–2030

        14.3.1. Oral

        14.3.2. Parenteral

    14.4. Market Value Forecast, by Distribution Channel, 2018–2030

        14.4.1. Hospital Pharmacies

        14.4.2. Retail Pharmacies

        14.4.3. Online Pharmacies

    14.5. Market Value Forecast, by Country/Sub-region, 2018–2030

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis 

        14.6.1. By Product Type 

        14.6.2. By Route of Administration 

        14.6.3. By Distribution Channel 

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Company Profiles

        15.1.1. Merck & Co., Inc.

            15.1.1.1. Company Overview

            15.1.1.2. Company Financials

            15.1.1.3. Growth Strategies

            15.1.1.4. SWOT Analysis

        15.1.2. Nature’s Bounty

            15.1.2.1. Company Overview

            15.1.2.2. Growth Strategies

            15.1.2.3. SWOT Analysis

        15.1.3. Sun Pharmaceutical Industries Ltd.

            15.1.3.1. Company Overview

            15.1.3.2. Company Financials

            15.1.3.3. Growth Strategies

            15.1.3.4. SWOT Analysis

        15.1.4. Pfizer, Inc.

            15.1.4.1. Company Overview

            15.1.4.2. Company Financials

            15.1.4.3. Growth Strategies

            15.1.4.4. SWOT Analysis

        15.1.5. Novartis AG 

            15.1.5.1. Company Overview

            15.1.5.2. Company Financials

            15.1.5.3. Growth Strategies

            15.1.5.4. SWOT Analysis

        15.1.6. Cipla, Inc.

            15.1.6.1. Company Overview

            15.1.6.2. Company Financials

            15.1.6.3. Growth Strategies

            15.1.6.4. SWOT Analysis

        15.1.7. DSM

            15.1.7.1. Company Overview

            15.1.7.2. Company Financials

            15.1.7.3. Growth Strategies

            15.1.7.4. SWOT Analysis

        15.1.8. BASF SE

            15.1.8.1. Company Overview

            15.1.8.2. Company Financials

            15.1.8.3. Growth Strategies

            15.1.8.4. SWOT Analysis

        15.1.9. Nestle

            15.1.9.1. Company Overview

            15.1.9.2. Company Financials

            15.1.9.3. Growth Strategies

            15.1.9.4. SWOT Analysis

        15.1.10. GlaxoSmithKline plc

            15.1.10.1. Company Overview

            15.1.10.2. Company Financials

            15.1.10.3. Growth Strategies

            15.1.10.4. SWOT Analysis

Choose License Type

Checkout Inquiry Sample